Cryo-electron microscopy (Cryo-EM) and drug design
Our research program is focused on exploring frontiers in structural biology and drug design using cryo electron microscopy (cryo-EM), with the central goal of accelerating the development of effective therapeutic agents. The program is guided by two overarching themes:
Drug Design

A highly focused team effort to use high-resolution cryo-EM imaging of native protein complexes to design effective therapeutic agents targeting cancer, infectious diseases and brain disorders.
Technology Development

An interdisciplinary approach towards developing next generation technologies in cryo-EM using state-of-the-art AI tools and automated workflows coupled with advanced image processing and machine learning.
News
-
Study challenges original theory about Canada’s first human case of bird flu
The Globe and Mail [September 28, 2026] University of British Columbia researchers say the unusual genetic mutations identified in Canada’s first human avian influenza case weakened the virus’ ability to bind to human cells, a critical first step in infection.
-
How does a bird virus infect a person? Surprising findings from B.C.’s human case of H5N1 avian flu
The Conversation Canada [September 28, 2026] Uncovering insights into how pathogens can switch from animals to humans — as in this human case of bird flu — can help researchers and public health agencies prepare for future outbreaks. In a recent study, our lab examined viral mutations in this case and uncovered an unexpected result:…
-
Canada’s first human bird flu case offers new clues for monitoring pandemic threats
The University of British Columbia Faculty of Medicine News [September 28, 2026] “We pay very close attention to mutations in this part of the virus because changes here can potentially help H5N1 adapt to humans,” said senior author Dr. Sriram Subramaniam, professor of biochemistry and molecular biology at the UBC faculty of medicine and investigator…








